Could an immune treatment ease severe OCD in kids with PANS?
NCT ID NCT04508530
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a medicine called Panzyga (given through a vein) can reduce obsessive-compulsive symptoms in children aged 6 to 17 with a condition called PANS or PANDAS. These children experience a sudden, severe onset of OCD and other neuropsychiatric problems. The study compared Panzyga to a placebo over 9 weeks, measuring changes in OCD severity using a standard rating scale. The goal was to see if Panzyga could provide meaningful symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Octapharma Research Site
Tucson, Arizona, 85712, United States
-
Octapharma Research Site
Little Rock, Arkansas, 72202, United States
-
Octapharma Research Site
Los Angeles, California, 90024, United States
-
Octapharma Research Site
Palo Alto, California, 94305, United States
-
Octapharma Research Site
Centennial, Colorado, 80112, United States
-
Octapharma Research Site
Boston, Massachusetts, 02114, United States
-
Octapharma Research Site
Lebanon, New Hampshire, 03756, United States
-
Octapharma Research Site
Genova, 16147, Italy
-
Octapharma Research Site
Roma, 00161, Italy
-
Octapharma Research Site
Roma, 00186, Italy
-
Octapharma Research Site
Gothenburg, 41685, Sweden
-
Octapharma Research Site
Stockholm, 17164, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.